To compare the 3-year incidence of major events in patients with bifurcation lesions treated with provisional sirolimus-eluting stents vs everolimus-eluting stents.
Pan, M., Burzotta, F., Trani, C., Medina, A., Suárez De Lezo, J., Niccoli, G., Romero, M., Porto, I., Mazuelos, F., Leone, A. M., Martín, P., Coluccia, V., Suárez De Lezo, J., Ojeda, S., Crea, F., Three-year follow-up of patients with bifurcation lesions treated with sirolimus- or everolimus-eluting stents: SEAside and CORpal cooperative study, <<REVISTA ESPAÑOLA DE CARDIOLOGÍA>>, 2014; 67 (10): 797-803. [doi:10.1016/j.rec.2013.10.016] [http://hdl.handle.net/10807/60741]
Three-year follow-up of patients with bifurcation lesions treated with sirolimus- or everolimus-eluting stents: SEAside and CORpal cooperative study
Burzotta, Francesco;Trani, Carlo;Niccoli, Giampaolo;Porto, Italo;Leone, Antonio Maria;Coluccia, Valentina;Crea, Filippo
2014
Abstract
To compare the 3-year incidence of major events in patients with bifurcation lesions treated with provisional sirolimus-eluting stents vs everolimus-eluting stents.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.